Skip to main content

Table 4 Simple Tobit regression (right ear)

From: Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity

Frequency (Hz)

No. of non-responses

Risk factors

Estimate of coefficient (SE); p-value

Age

HIV Seropositive

NCD

LFPTT

125

0

0.2 (0.09); 0.02

1.15 (1.98); 0.56

2.33 (2.16); 0.28

250

0

0.26 (0.1); 0.01

3.8 (2.24); 0.09

− 0.42 (2.58); 0.87

500

0

0.25 (0.1); 0.01

5.89 (2.23); 0.01

− 0.46 (2.66); 0.86

MFPTT

1000

1

0.11 (0.12); 0.38

3.52 (2.68); 0.19

− 2.52 (3.08); 0.41

2000

0

0.32 (0.13); 0.01

3.33 (3.04); 0.27

− 0.3 (3.54); 0.93

HFPTT

4000

0

0.56 (0.14); 0.01

8.21 (3.2); 0.01

1.0 (3.71); 0.79

8000

0

0.86 (0.17); 0.01

10.97 (4.02); 0.01

3.21 (4.6); 0.48

9000

0

1.13 (0.17); 0.01

11.4 (4.51); 0.01

4.37 (5.17); 0.39

EHFPTT

10,000

1

1.29 (0.19); 0.01

14.41 (4.97); 0.01

2.64 (5.83); 0.65

11,200

1

1.37 (0.20); 0.01

16.90 (5.25); 0.01

3 (6.17); 0.63

12,500

12 (14.6%)

1.79 (0.21); 0.01

21.57 (5.78); 0.01

− 5.45 (6.92); 0.43

14,000

31 (37.8%)

2.04 (0.27); 0.01

24.62 (6.63); 0.01

− 3.95 (7.88); 0.62

16,000

57 (70%)

1.64 (0.34); 0.01

22.16 (7.06); 0.01

− 5.1 (6.85); 0.46

18,000

75 (91%)

0.47 (0.22); 0.03

5.31 (3.84); 0.17

1.06 (2.92); 0.72

20,000

79 (96%)

0.42 (0.51); 0.14

8.7 (0.88); 0.01

− 0.95 (1.23); 0.44

  1. A positive coefficient of an estimate indicates that the mean of hearing loss increase with the value of the potential risk factor. The higher the estimate the higher the hearing loss
  2. Reference categories: HIV = 0 and NCD (Hypertension and Diabetes) = 0
  3. LFPTT, Low-frequency pure tone thresholds; MFPTT, Mid-frequency pure tone thresholds, HFPTT, High frequency pure tone thresholds; EHFPTT Extended high-frequency pure tone thresholds